Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00390104 · ClinicalTrials.gov registry record
Molecular Analysis of Patients With Neuromuscular Disease
A clinical trial of Limb Girdle Muscular Dystrophy and Neuromuscular; Disorder, Hereditary, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT00390104: Recruiting study of Limb Girdle Muscular Dystrophy and Neuromuscular; Disorder, Hereditary, sponsored by Boston Children's Hospital.
NCT00390104 is a study of Limb Girdle Muscular Dystrophy and Neuromuscular; Disorder, Hereditary that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 1,000 participants, above the 73-participant average among 6 other Limb Girdle Muscular Dystrophy trials with a reported enrollment target (1270% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00390104, a study of Limb Girdle Muscular Dystrophy and Neuromuscular; Disorder, Hereditary, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify new genes responsible for neuromuscular disorders and study muscle tissue of patient with known neuromuscular disease, as well as their family members. We are interested in recruiting many types of neuromuscular disease including; Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and limb-girdle muscle dystrophy (LGMD). There are still many patients diagnosed with muscular dystrophy with no causative gene implicated in their disease. Using molecular genetics to unravel basis of these neuromuscular disorders will lead to more accurate diagnosis/prognosis of these disorders which will lead to potential therapies.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2002-01 |
| Est. Completion | 2027-12-31 |
What NCT00390104 shows while recruiting
NCT00390104 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 73-participant average among 6 other Limb Girdle Muscular Dystrophy trials with a reported enrollment target (1270% higher).
The record links to 3 conditions, with Limb Girdle Muscular Dystrophy appearing as the primary indexed condition, and to 0 interventions.
NCT00390104 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00390104 about?
NCT00390104 is a clinical study titled "Molecular Analysis of Patients With Neuromuscular Disease". The purpose of this study is to identify new genes responsible for neuromuscular disorders and study muscle tissue of patient with known neuromuscular disease, as well as their family members. We are interested in recruiting many types of neuromuscular disease including; Duchenne muscular dystrophy ...
What is the current status of trial NCT00390104?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2002-01. Estimated completion is 2027-12-31.
What conditions does trial NCT00390104 study?
This clinical trial studies the following conditions: Limb Girdle Muscular Dystrophy, Neuromuscular; Disorder, Hereditary, Duchenne/Becker Muscular Dystrophy.
Who is sponsoring clinical trial NCT00390104?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00390104 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Limb Girdle Muscular Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
RECRUITING · Phase 1
-
LGMD R1 Natural History Study
RECRUITING
-
A Gene Transfer Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of SRP-9003 in Non-Ambulatory and Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2E/R4 (Beta-Sarcoglycan [β-SG] Deficiency)
ACTIVE NOT RECRUITING · Phase 1
-
A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4
ACTIVE NOT RECRUITING · Phase 3
-
A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice
ACTIVE NOT RECRUITING
-
Biomarker Development in LGMD2i
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia